Shares of Astex Pharmaceuticals (NASDAQ: ASTX) declined on Wednesday, a move related to de-risking ahead of tomorrow's expected approval of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE